doaa m. salah lecturer of pediatrics 2015. prevalence risk factors. impact on graft function ...
TRANSCRIPT
![Page 1: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/1.jpg)
Post kidney transplantation VUR
Doaa M. SalahLecturer of Pediatrics
2015
![Page 2: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/2.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KTX
![Page 3: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/3.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 4: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/4.jpg)
The exact incidence of post TX VUR unknown as most cases asymptomatic and the only diagnostic tools is VCUG (not routine)
![Page 5: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/5.jpg)
In pediatrics, frequency is 36%, 34%, 55% in 3 studies done in 1987, 1999, 2000 respectively compared to 2- 80% in adults.
Prevalence
![Page 6: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/6.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 7: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/7.jpg)
(Bootsma., etal.,The clinical significance of VUR into transplanted kidney,clinical. Transplantation. 1987;1: 311-315).
Risk Factors
Primary disease
Bladder capacity
Duration of RRT
Procedure of ureteral
anastomosis
Donor Type
![Page 8: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/8.jpg)
The gender has no impact on VUR rate after renal transplant.
But male liable to develop post transplant retention while female have increased risk of UTI.
(Farr et al., transplantaion,2014)
![Page 9: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/9.jpg)
Primary Reflux
![Page 10: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/10.jpg)
![Page 11: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/11.jpg)
Even after surgical correction of VUR before transplantation the frequency of f UTI remained higher than that in kidney transplant recipients without VUR.
J Urol. 2006; 175(4):1490-2
Does pre-transplantation antireflux surgery eliminate post-renal transplantation pyelonephritis in children?
![Page 12: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/12.jpg)
Bladder capacity decrease because of long term dialysis, it exceed 150 ml at 1 year post transplantation
A small bladder can be used in renal transplantation but it may increase the risk of VUR.
(Takamitsue et al., Correlation between pre transplant dialysis duration, bladder capacity and prevelance of VUR to the graft,
Transplantation.2011;92:311-315)
![Page 13: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/13.jpg)
Before implantation of donor kidney in the recipient
(International Journal of Urology, 2011)
Cystoplasty
Role of surgeon before TX is lower UT
Sterile Continent Compliant
![Page 14: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/14.jpg)
![Page 15: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/15.jpg)
![Page 16: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/16.jpg)
![Page 17: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/17.jpg)
![Page 18: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/18.jpg)
The slandered is ureteroneocystostomy(trans vesical or extra vesical, antireflux and non antireflux) If double ureters…. managed as double blood supply to
some extend Other alternatives as ureteroenterostomy in intestinal
conduit or pouch or pyelovesicostomy if the native ureter and graft ureter are unsuitable for urinery tract reconstruction.
Urinary tract reconstruction in TX
![Page 19: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/19.jpg)
![Page 20: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/20.jpg)
![Page 21: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/21.jpg)
The Lich-Gregoir anastomosis is created by performing a cystotomy for 2 to 3 cm on the anterolateral surface of the bladder dome to expose mucosa of the bladder wall. A small incision is made in the mucosa. The transplanted ureter is trimmed and spatulated posteriorly. The mucosa of the bladder is sutured to the ureteral end with interrupted absorbable sutures. The detrusor muscle is closed over the anastomosis to create a submucosal tunnel with an antireflux mechanism
![Page 22: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/22.jpg)
The Politano-Leadbetter anastomosis is created by performing a cystotomy on the anterior side to visualize the interior of the bladder and expose the trigone. A second cystotomy is performed to create a new ureteric orifice. The transplanted ureter is tunneled submucosally for approximately 2 cm. The distal site is trimmed and spatulated anteriorly at an optimal length to ensure a tension-free anastomosis. The distal ureter is sutured to the bladder mucosa with interrupted absorbable stitches. The cystotomy is closed in two layers to ensure a watertight anastomosis.
![Page 23: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/23.jpg)
LG significantly associated with lower incidence of urinary leakage and hematuria but no significant difference in stricture or reflux
(Victor et al.,ureterovesical anastomosis techniques: systemic review and meta-analysis. Transplant international 2014)
Techniques of ureter vesical anastomosis
![Page 24: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/24.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 25: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/25.jpg)
Controversial
Impact on graft function
![Page 26: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/26.jpg)
Immediate graft dysfunction (first week) Early graft dysfunction (1-12 week) Late acute graft dysfunction (>3monthes) Chronic graft dysfunction (years)
Graft Dysfunction
![Page 27: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/27.jpg)
![Page 28: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/28.jpg)
Nephrol.Dial.Transplant (2000);15: 1852-1858.
![Page 29: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/29.jpg)
![Page 30: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/30.jpg)
VUR increase the risk of UTI and pyelonephriyis VUR possibly lead to hypertenstion and CAN
(Howie et al., Reflux nephropathy in transplants. Pediatri Nephrol 2002;17: 485)
(Favi et alm, long term clinical impact of VUR in KTX. Transplant Proceedings 2009;41:1218)
![Page 31: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/31.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 32: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/32.jpg)
![Page 33: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/33.jpg)
Lower UT evaluation
(voiding diary)
Prevention
![Page 34: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/34.jpg)
![Page 35: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/35.jpg)
Lower UT evaluation
VCUG(Detruser capacity, deformity, VUR , uretheral abnormality)
Prevention
![Page 36: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/36.jpg)
![Page 37: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/37.jpg)
![Page 38: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/38.jpg)
![Page 39: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/39.jpg)
Lower UT evaluation
VUDS (detruser evaluation: capacity, contractilitym, compliance, dysynergyia). Bladder deformity, VUR and uretheral deformability
Prevention
![Page 40: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/40.jpg)
![Page 41: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/41.jpg)
![Page 42: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/42.jpg)
Studies evaluating VCUGs in asymptomatic renal transplant recipients have revealed VUR rates up to 86%
Pre protocol VCUG early after transplantation ??? The incidence of VUR is high although antireflux
procedures used for implantation
(American Journal of Transplantation 2013;13:130-135)
Prevention
![Page 43: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/43.jpg)
Universal prophylaxis involves giving an antimicrobial agent to all patients.
Trimethoprim-sulfamethoxazole (TMP-SMX) is given universally to all transplant recipients who do not have sulfa allergies.
TMP-SMX is effective for the prevention of Pneumocystis pneumonia (PCP).
It provides effective prophylaxis against other pathogens, including Listeria monocytogenes and Toxoplasma gondii.
(Fishman et al., 1998)
Antibiotic Prophylaxis
![Page 44: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/44.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 45: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/45.jpg)
Routine functional studies not indicated in potential recipients Recipients with neurovesical dysfunction VCUG and
pressure flow urodynamic study with or without cystoscopy High pressure urine storage antimuscarinic
medications or CISC before TX Oliguric pt. start CISC before TX to allow teaching
the family Those unable to carry CISC urinery diversion
(suprapupic cath, conduit, pouch or augmentation)
(International Journal of Urology, 2011;18:185-193)
Bladder Dysfunction
![Page 46: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/46.jpg)
Long term Ab prophylaxis is sufficient for the majority of cases with post TX VUR
Antibiotic Prophylaxis
![Page 47: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/47.jpg)
Surgical intervention is only indicated in intractable cases
(recurrent graft UTI, UTI refractory to therapy with grade 4 to 5 reflux result in renal scaring or compromise graft function) Reimplantation Endoscopic injection of a bulking substance to the
muscular post wall of the ureter vesical junction
Surgery
![Page 48: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/48.jpg)
PrevalenceRisk Factors.Impact on graft functionPreventionManagement Center study
VUR post KT
![Page 49: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/49.jpg)
54 pediatric transplant recipient All received antibiotic prophylaxsis at least 6 mo
Obstructive uropathy diseases in 24% (included PUV 12.9%, vesicoureteric reflux 9.3%, neurogenic baldder 1.9%) 40% had UTI during their F/U period 54% of the episodes were in first 6 mo (40% had recurrent UTI, 2% simple non recurrent UTI,
50% asymptomatic bacturia, 9% had pyelonephritis) UTI significantlly higher in cases with primery obstructive
uropathy
Center Study
![Page 50: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/50.jpg)
Febrile UTI represents 40.9% of the studied UTI group compared to 54.4% with no symptoms.
6 cases (27% of UTI cases had variable degrees of VUR )
The outcome (graft survival) was similar in UTI and non UTI cases. Although UTI tend to affect graft function in low GFR levels <60 ml/min/1.73m2
![Page 51: Doaa M. Salah Lecturer of Pediatrics 2015. Prevalence Risk Factors. Impact on graft function Prevention Management Center study](https://reader036.vdocuments.mx/reader036/viewer/2022062713/56649cef5503460f949bcf44/html5/thumbnails/51.jpg)
Thank you